newsfilter
← Latest News
Business Wire·

Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial

Ra Medical Systems, Inc. (NYSE:RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its pivotal clinical trial to evaluate the safety and effectiveness